SCM
VIR icon

Sio Capital Management’s Vir Biotechnology VIR Stock Holding History

Sio Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.4M Buy
1,498,620
+1,020,277
+213% +$8.13M 1.93% 16
2025
Q4 		$2.88M Hold
478,343
– – 0.45% 43
2025
Q3 		$2.73M Hold
478,343
– – 0.69% 33
2025
Q2 		$2.41M Buy
478,343
+4,736
+1% +$25.4K 0.92% 29
2025
Q1 		$3.07M Sell
473,607
-581,044
-55% -$5.17M 0.91% 26
2024
Q4 		$7.74M Buy
+1,054,651
New +$8.32M 2.18% 16

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Sio Capital Management's VIR Position: Q1 2026 in Review

Sio Capital Management increased its Vir Biotechnology (VIR) stake by 213% in Q1 2026, buying an estimated $8.13M and bringing the position to 1,498,620 shares worth $13.4M. The position accounts for 1.93% of the portfolio, ranked #16.

Sio Capital Management first reported a position in VIR in Q4 2024 and has held it in 6 quarters since. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Sio Capital Management held 1,498,620 shares of Vir Biotechnology worth $13.4M as of Q1 2026.
  • Sio Capital Management bought 1,020,277 Vir Biotechnology shares in Q1 2026, an estimated $8.13M.
  • Vir Biotechnology made up 1.93% of Sio Capital Management's portfolio in Q1 2026, its #16 holding.
  • Sio Capital Management first reported a position in Vir Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Sio Capital Management's 13F filing for Q1 2026, filed 14 May 2026.